Ex-FDA chief Gottlieb pushes for antibody manufacturing scale up as 2021 pandemic ‘insurance policy’ fkansteiner Tue, 12/15/2020 – 11:00 More: Ex-FDA chief Gottlieb pushes for antibody manufacturing scale up as 2021 pandemic 'insurance policy' Source: fierce
read moreRoche’s MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion aliu Tue, 12/15/2020 – 10:11 More: Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion Source: fierce
read moreBiogen superspreader meeting spawned 300,000-plus U.S. coronavirus cases: study esagonowsky Tue, 12/15/2020 – 09:40 More: Biogen superspreader meeting spawned 300,000-plus U.S. coronavirus cases: study Source: fierce
read moreLilly eyes up to $2B in COVID-19 sales by year-end—plus revenue boosts in cancer, diabetes and more arlene.weintraub Tue, 12/15/2020 – 09:36 More: Lilly eyes up to B in COVID-19 sales by year-end—plus revenue boosts in cancer, diabetes and more
read morePfizer/BioNTech weren’t alone: Moderna COVID-19 vaccine data targeted in EMA cyberattack aliu Tue, 12/15/2020 – 08:44 More: Pfizer/BioNTech weren't alone: Moderna COVID-19 vaccine data targeted in EMA cyberattack Source: fierce
read moreThe Russian Direct Investment Fund has released a new analysis of data obtained 21 days after administering the first dose of the vaccine, showing efficacy of 91.4% More: RDIF confirms Sputnik V COVID vaccine’s efficacy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals